Information on the target
OneMed Group, a prominent player in the healthcare sector, is set to acquire a 75% majority shareholding in Hand-Prod Group, the leading wholesaler of healthcare products in Poland. This strategic acquisition aims to enhance OneMed's market presence in Northern Europe. Hand-Prod Group operates a diverse portfolio that includes associate companies such as Homeofarm, Blau-Farma, and Dia-Pol, all of which are part of this transaction. The Group's clientele encompasses public and private hospitals, laboratories, medical centers, pharmacies, and pharmaceutical wholesalers, showcasing its extensive reach within the healthcare supply chain.
With an annual turnover of approximately EUR 100 million, Hand-Prod Group has established a strong foothold in diagnostic and surgical products, as well as specialty pharmaceuticals for hospital use. Additionally, the Group is expanding its operations into the service sector, currently developing a network of dialysis stations across Poland. Employing 155 individuals at its headquarters in Warsaw and six regional sales offices, Hand-Prod Group is well-positioned for continued growth and operational success.
Industry overview in the target’s specific country
The healthcare industry in Poland has experienced significant growth in recent years, driven by an ageing population and increasing government and private funding for pharmaceuticals and healthcare supplies. This growth trajectory is expected to continue, creating a favorable environment for companies like Hand-Prod Group. The Polish healthcare market is characterized by a mix of public and private sector involvement, with a growing demand for high-quality medical products and services.
As the population ages, there is a rising need for healthcare services, particularly in areas such as diagnostics, surgical procedures, and specialty pharmaceuticals. This demographic shift is prompting healthcare providers to seek reliable suppliers who can offer a comprehensive range of products to meet their evolving needs. Hand-Prod Group's established reputation and extensive product offerings position it well to capitalize on these trends.
Moreover, the Polish government has been increasing its investment in healthcare infrastructure, which further supports the growth of the industry. Initiatives aimed at improving healthcare access and quality are likely to drive demand for healthcare products, thereby benefiting wholesalers like Hand-Prod Group. The company's strategic expansion into the service sector, particularly with the development of dialysis stations, aligns well with the market's needs and enhances its competitive advantage.
The rationale behind the deal The acquisition of Hand-Prod Group by OneMed Group is driven by the strategic intent to strengthen OneMed's position as a leading healthcare and laboratory products provider in Northern Europe. The complementary product ranges and distribution channel…